A Study in Adults With Type 2 Diabetes
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 759 participants.
Also called NCT01421459
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 759 participants
- Registry
-
NCT01421459 -
2011-000828-15
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Czechia, France, Germany, Greece, Hungary, Mexico, Poland, Puerto Rico, South Korea, Spain, Taiwan
- Registry status
- Completed
Technical summary
Registry record NCT01421459. Randomized; triple masking; primary purpose treatment. Start 2011-09 (registry gives no type); primary completion 2012-09 (actual). Results posted on 2014-10-09.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study in Adults With Type 2 Diabetes
- Acronym
- ELEMENT 2
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- LY2963016
- Intervention (Drug)
- Lantus
- Intervention (Drug)
- OAMs
- Lead sponsor
- Eli Lilly and Company
- Collaborator
- Boehringer Ingelheim
Record details
- Record id
cardio:ct-nct01421459- Content hash
9540ced352500a9483eb8207162f543ffd77f8fc2cf4bfe08d55c2ea87a7338b